ArticleCancer medicine2025

DGKα Enhances Tumorigenic Activity in Bladder Cancer Patients With Chronic Kidney Disease.

Kenshiro Takemoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.